News

Genèse Labs Announces the Global Launch of RG60® Body Filler

2024-11-10

본문

eaa9e83078771c15c7eaff9b77d1663a_1764481076_2407.png


Genèse Labs Announces the Global Launch of RG60® Body Filler
 
Genèse Labs is proud to announce the worldwide launch of RG60®, a next-generation body filler developed to provide volume restoration,
contour enhancement, and natural sculpting results for the body. As the company’s first major international product release, RG60® marks
the beginning of Genèse Labs’ growth into the global medical aesthetics industry.




A New Standard in Body Contouring

RG60® was created in response to the rising demand for safe, stable, and long-lasting volumising fillers dedicated to body indications.

Through advanced Korean aesthetic manufacturing and extensive formulation research, RG60® offers high cohesiveness and structural

strength for large-body areas, excellent tissue integration for natural contouring, smooth and stable extrusion force for controlled application,

and long-lasting volume with predictable results. Initially launched in two variants, RG60® provides flexibility for practitioners. RG60®

(Standard Formula) is strong, volumizing, and ideal for structural contouring, while RG60+® (with Lido) is formulated with lido (lidocaine)

to enhance patient comfort during procedures. This dual-release ensures physicians can select the formula most appropriate for each patient

and treatment plan.




Designed for Professional Performance

RG60® is engineered to support practitioners in delivering aesthetic results that are both natural and durable. The filler’s viscoelastic profile

enables precise shaping, while its high cohesiveness ensures that volume stays where intended, even in mobile body areas. Key professional

advantages include reliable gel stability suitable for high-volume applications, strong projection capability for body enhancement, a

comfort-focused option (RG60+®) for sensitive patients, and user-friendly packaging tailored for clinical needs. These features position RG60®

as a trusted tool for clinics specializing in advanced body contouring.




Commitment to Quality & Safety

As a Korea-based aesthetics manufacturer, Genèse Labs upholds rigorous standards of quality control, purity testing, and product safety

validation. Each batch of RG60® undergoes endotoxin testing, sterility evaluation, cohesiveness and elasticity measurement, and packaging

integrity checks. These controls ensure that RG60® meets the expectations of practitioners in Europe, the Middle East, Asia, and Latin America.




A Milestone for Genèse Labs

The launch of RG60® represents the company’s first major international expansion step. It reflects Genèse Labs’ mission to develop scientifically

advanced aesthetic products and introduce Korean innovation to a global audience. “We are excited to bring RG60® to practitioners worldwide,”

said the Genèse Labs team.  “This product marks the beginning of our commitment to offering high-performance aesthetic solutions tailored to

professional needs.”





Global Availability

RG60® and RG60+® are now available through Genèse Labs’ certified distributors.

For commercial or clinical inquiries, please contact:

 [email protected]

▶ www.geneselabs.net



추천0